Showing results (1771-1780 of 1,810) with videos related to
Sort By:
Pageof 181
Cell Metabolism|December 14, 2024
FcRn-dependent IgG accumulation in adipose tissue unmasks obesity pathophysiologyLexiang Yu, Yong Xiao Yang, Zhen Gong, et al.JAMA Network Open|December 20, 2021
Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical TrialQing-Nan Tang, Li-Ting Liu, Bin Qi, et al.Gastroenterology|April 30, 2022
β-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in CholangiocarcinomaYi Zhang, Hongwei Xu, Guofei Cui, et al.Structural Dynamics (Melville, N.Y.)|April 28, 2025
Femtosecond charge and spin dynamics in a Co50Pt50 alloyMartin Pavelka, Simon Marotzke, Ru-Pan Wang, et al.The Journal of Clinical Investigation|May 1, 2026
Helicobacter pylori-induced PPFIA4 orchestrates immune network-promoting gastritis and gastric bacterial colonizationPan Wang, Nan You, Yong-Sheng Teng, et al.Nature Communications|July 4, 2025
Broadband near-infrared hyperbolic polaritons in MoOCl2Yaolong Li, Yuxin Zhang, Weizhe Zhang, et al.Science (New York, N.Y.)|June 1, 2023
Tracking C-H activation with orbital resolutionRaphael M Jay, Ambar Banerjee, Torsten Leitner, et al.Science China. Life Sciences|October 20, 2023
Potentiation of the lateral habenula-ventral tegmental area pathway underlines the susceptibility to depression in mice with chronic painChun-Kui Zhang, Pan Wang, Yuan-Yuan Ji, et al.Frontiers in Immunology|October 10, 2022
PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching studyKe Su, Lu Guo, Wenqiong Ma, et al.Cancer Communications (London, England)|November 2, 2018
Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation StudyQiuyan Chen, Linquan Tang, Na Liu, et al.Pageof 181